RETA - Reata Pharmaceuticals Inc
IEX Last Trade
0 0%
Share volume: 0
Last Updated:
Pharmaceutical Preparation Manufacturing :
-2.77%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-05-10 | 2022-08-08 | 2022-11-08 | 2023-02-24 | 2023-05-10 | 2023-08-08 | |
| Assets | |||||||
| Total Assets | 679.868 M | 631.549 M | 583.644 M | 514.491 M | 453.582 M | 502.587 M | |
| Current Assets | 537.336 M | 491.210 M | 445.104 M | 397.770 M | 332.542 M | 401.849 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 2.942 M | |
| Other Current Assets | 5.357 M | 9.739 M | 9.229 M | 10.256 M | 11.583 M | 46.031 M | |
| Short Term Investments | 5.357 M | 9.739 M | 9.229 M | 10.256 M | 11.583 M | 46.031 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 22.662 M | |
| Current Cash | 531.979 M | 481.471 M | 435.875 M | 387.514 M | 320.959 M | 330.214 M | |
| Total Non-current Assets | 142.532 M | 140.339 M | 138.540 M | 116.721 M | 121.040 M | 100.738 M | |
| Property Plant Equipment | 11.202 M | 11.033 M | 11.263 M | 11.179 M | 11.060 M | 11.303 M | |
| Other Assets | 152.000 K | 147.000 K | 142.000 K | 284.000 K | 6.173 M | 10.837 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 679.868 M | 631.549 M | 583.644 M | 514.491 M | 453.582 M | 502.587 M | |
| Total liabilities | 552.083 M | 562.913 M | 579.128 M | 580.186 M | 584.255 M | 415.295 M | |
| Total current liabilities | 43.620 M | 46.325 M | 50.711 M | 58.960 M | 54.598 M | 125.092 M | |
| Accounts Payable | 9.015 M | 7.754 M | 7.518 M | 18.706 M | 14.448 M | 19.860 M | |
| Other liabilities | 372.018 M | 382.295 M | 392.958 M | 403.913 M | 414.930 M | 126.656 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 73.130 M | |
| Other liabilities | 372.018 M | 382.295 M | 392.958 M | 403.913 M | 414.930 M | 126.656 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 127.785 M | 68.636 M | 4.516 M | -65.695 M | -130.673 M | 87.291 M | |
| Common stock | 36.413 M | 36.468 M | 36.537 M | 36.654 M | 36.948 M | 37.672 M | |
| Retained earnings | -1.329 B | -1.403 B | -1.482 B | -1.568 B | -1.684 B | -1.491 B |